About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 68 record(s)
Req # A-2023-35
List of businesses/companies that received IRAP funding from January 1, 2021 to present (2024-01-29). Only the names of the businesses and their websites if available.Organization: National Research Council Canada
February 2024
Req # A-2023-38
All records for the years 1890-1920 relating to the Medical Research Committee and the Medical Research Council of Canada.Organization: National Research Council Canada
February 2024
Req # A-2024-54596
Submission of the Public Health Agency of Canada (PHAC) to the Patented Medicine Prices Review Board’s November 2023 consultation on the Scoping paper of the Board's Guidelines. Submissions from other stakeholders can be viewed here: https://www.canada.ca/en/patented-medicine-prices-review/services/consultations/scoping-paper-board-guidelines.htmlOrganization: Patented Medicine Prices Review Board Canada
February 2024
Req # A-2022-56
All records relating to registered lobbying communication #517778 involving Iain Stewart, President, National Research Council (NRC) and IBM Canada Ltd. on November 29, 2021. All records relating to registered lobbying communication #502234 involving Mitch Davies, President, National Research Council (NRC) and IBM Canada Ltd. on March 10, 2021.Organization: National Research Council Canada
April 2023
Req # A-2022-60
All grant and contribution agreements, amendments, and final reports arising from agreements with Greenspace Mental Health. Any correspondence between NRC and the Public Health Agency of Canada regarding these agreements.Organization: National Research Council Canada
April 2023
Req # A-2022-05126
Provide all emails with keyword “ATIP” from May 1, 2021 to February 23, 2022.Organization: Patented Medicine Prices Review Board Canada
April 2023
Req # A-2023-11914
Number of instances in which the ATIP unit used section 20(6) (the public interest override) of the Access to Information Act, as tallied by the documentation retained in accordance with the Manual. No time limit; assess based on period of available documentation (and please indicate this period).Organization: Patented Medicine Prices Review Board Canada
April 2023
Req # A-2021-24940
Provide all emails sent to/from Tanya Potashnik from May 1, 2021, to December 19, 2021. Exclude media scans.Organization: Patented Medicine Prices Review Board Canada
April 2023
Req # A-2023-02395
Copies of all correspondence and communications between the (then) acting chairperson of the Patented Medicines Prices Review Board Mélanie Bourassa-Forcier and Innovative Medicines Canada (IMC) between October 1, 2022 and December 5, 2022 regarding the PMPRB's new draft guidelines and the consultation process. Please include all responses to Innovative Medicines Canada (IMC)'s communications/correspondence from the (then) acting chairperson of the Patented Medicines Prices Review Board Mélanie Bourassa-Forcier.Organization: Patented Medicine Prices Review Board Canada
February 2023
Req # A-2022-09063
Copies of any emails sent by the Vice-chair regarding any of the following topics: (i) her resignation or intent to resign or the reasons for her resignation. (ii) the draft guidelines. (iii) the consultation process for the draft guidelines. (iv) the impact of the Merck Canada, IMC, and/or Alexion court decisions on the PMPRB, including its draft guidelines. From November 1, 2022 to December 5, 2022.Organization: Patented Medicine Prices Review Board Canada
February 2023